PATENT CLAIM ANALYSIS

Application Number: 16020531
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "017700"]

Abstract:
Polypeptides including Neurochondrin and autoantibodies binding to polypeptides including Neurochondrin are provided. Methods for diagnosing or treating diseases associated with neurological symptoms or cancers are also provided. The methods of diagnosis may include detecting an autoantibody binding to Neurochondrin in a sample from a patient. The methods of treatment may include administering a polypeptide comprising Neurochondrin to a patient.

Claim (Index 23):
The method of  claim 16 , wherein the detecting the presence or absence of the autoantibody to Neurochondrin in a complex with the polypeptide comprises the use of a secondary antibody.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 94.0
- Lexical Diversity: 1.53659
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15078361', '15954019', '14822045', '15172450', '14000221']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7088214722850912
- 35 USC 102 Novelty (BERT): 0.5276424161810428
- Combined Prediction Score: 0.6907035666746864
- Mean Citation Score: 238.06573000000003
- Max Citation Score: 311.9436
- Similarity Product: 226.75624086434848

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test